title: A 67-year-old woman receiving tumor necrosis factor α inhibitor therapy presenting with neurologic dysfunction.
authors.affiliation: Oregon Health & Science University, Portland, OR 97239, USA. gargn@ohsu.edu
authors.forename: Neha
authors.initials: N
authors.lastname: Garg
authors.forename: Randy
authors.initials: R
authors.lastname: Woltjer
authors.forename: Bronwyn
authors.initials: B
authors.lastname: Hamilton
authors.forename: Edward A
authors.initials: EA
authors.lastname: Neuwelt
authors.forename: James T
authors.initials: JT
authors.lastname: Rosenbaum
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D003072:Cognition Disorders / Q000139:chemically induced* / Q000175:diagnosis; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D000069285:Infliximab; D008279:Magnetic Resonance Imaging; D010292:Paresthesia / Q000139:chemically induced* / Q000175:diagnosis; D014057:Tomography, X-Ray Computed; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab